HLA-B*1502 Detection

DNA Genetic Tests

 
HLA-B*1502 Detection -  |

HLA-B*1502 Detection

Relating to Drug:

Carbamazepine & Phenytoin

HLA-B*1502 Detection
RT-PCR & SYBR Green based detection method: each sample requires only 2 PCR rxns for detecting of HLA-B*1502 and Internal Control. Analysis is based on Ct values. A complete kit version has IVD approval from Department of Health, Taiwan.
 

Product Features

  • Required only hours from blood sample to results.
  • Designed for easy operation & analysis.
  • Validated accuracy with 4500+ patients samples* & DNA sequencing.
  • Protected by US, Europe & world wide patents.
  • Mix & Match design.
Regulatory Status
HLA-B*1502 Detection
 
Taiwan IVD
China IVD
US ASR

 

 

 

 

 

Many studies have demonstrated the strong association of Human Leukocyte Antigen (HLA-B*1502) and carbamazepine, phenytoin, & oxcarbazepine induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Individuals that use DNA tests to determine their HLA genotypes prior to taking these drugs can reduce their risks of developing SJS/TEN by as high as 1300 times.

Product Performance

HLA-B*1502 Table

Test Process

HLA-B*5701Test 

Our HLA-B*1502 detection test is unable to distinguish the following rare allele types:
HLA-B*1513, 1531, 1555, 1588, 1589, 1820, 9512, 9521, 9544, 9570

TAGHLA-B*1502CarbamazepinephenytoinSJSTEN,